These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32053702)

  • 41. Management, hospital outcome and revascularization trends in non-ST elevation myocardial infarction with high GRACE risk score.
    Akhter Z; Rind IA; Aijaz S; Sattar S; Malik R; Pathan A
    J Pak Med Assoc; 2019 Oct; 69(10):1486-1492. PubMed ID: 31622302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
    Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating mortality in survivors of the acute coronary syndrome by the 4-drug score.
    Kopel E; Klempfner R; Goldenberg I; Schwammenthal E
    Cardiology; 2014; 127(2):83-9. PubMed ID: 24280900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting.
    Bezin J; Klungel OH; Lassalle R; Dureau-Pournin C; Moore N; Pariente A
    Clin Pharmacol Ther; 2018 Jun; 103(6):1038-1046. PubMed ID: 28875506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of increasing age with receipt of specialist care and long-term mortality in patients with non-ST elevation myocardial infarction.
    Zaman MJ; Fleetcroft R; Bachmann M; Sarev T; Stirling S; Clark A; Myint PK
    Age Ageing; 2016 Jan; 45(1):96-103. PubMed ID: 26601697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of hypertension on the outcome of patients admitted with acute coronary syndrome.
    Erne P; Radovanovic D; Schoenenberger AW; Bertel O; Kaeslin T; Essig M; Gaspoz JM;
    J Hypertens; 2015 Apr; 33(4):860-7. PubMed ID: 25915891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
    J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study.
    Nguyen T; Le KK; Cao HTK; Tran DTT; Ho LM; Thai TND; Pham HTK; Pham PT; Nguyen TH; Hak E; Pham TT; Taxis K
    BMJ Open; 2017 Oct; 7(10):e017008. PubMed ID: 28982823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of evidence-based management for acute coronary syndrome.
    Tang E; Wong CK; Wilkins G; Herbison P; Williams M; Kay P; Restieaux N
    N Z Med J; 2005 Oct; 118(1223):U1678. PubMed ID: 16224502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pre-hospital cardiac arrest in acute coronary syndromes: insights from the global registry of acute coronary events and the canadian registry of acute coronary events.
    Li Q; Goodman SG; Yan RT; Gore JM; Polasek P; Lai K; Baer C; Goldberg RJ; Pinter A; Ahmad K; Kornder JM; Yan AT;
    Cardiology; 2013; 126(1):27-34. PubMed ID: 23860213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.
    Gencer B; Rodondi N; Auer R; Räber L; Klingenberg R; Nanchen D; Carballo D; Vogt P; Carballo S; Meyer P; Matter CM; Windecker S; Lüscher TF; Mach F
    Eur J Intern Med; 2015 Jan; 26(1):56-62. PubMed ID: 25582072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guideline-Based Medications for Older Adults Discharged after Percutaneous Coronary Intervention in a Suburban City of Japan: A Cohort Study Using Claims Data.
    Shimada K; Hamada S; Sawano M; Yamamoto H; Yoshie S; Iijima K; Miyata H
    Tohoku J Exp Med; 2020 Oct; 252(2):143-152. PubMed ID: 33028759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000-2007.
    Aliprandi-Costa B; Ranasinghe I; Chow V; Kapila S; Juergens C; Devlin G; Elliott J; Lefkowitz J; Brieger DB
    Med J Aust; 2011 Aug; 195(3):116-21. PubMed ID: 21806528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry.
    Nguyen HL; Goldberg RJ; Gore JM; Fox KA; Eagle KA; Gurfinkel EP; Spencer FA; Reed G; Quill A; Anderson FA
    Coron Artery Dis; 2010 Sep; 21(6):336-44. PubMed ID: 20661139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.